8-K:重大事件
S-8:员工福利计划证券登记
8-K:重大事件
8-K:Reviva公布2024年第一季度财务业绩和近期业务亮点
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | NT 10-K:其他
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | S-3:特定交易注册声明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K/A:重大事件(修正)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:Reviva公布2023年第三季度财务业绩和近期业务亮点
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | DEF 14A:股东委托书决议
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:Reviva公布2023年第二季度财务业绩和近期业务亮点
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
暂无数据